Generate a tailored SOP for Dr. Karijn Suijkerbuijk. Improve your application with a focused, well-structured draft.
Karijn Suijkerbuijk is a translational medical oncologist with a special interest in melanoma immunotherapy. She completed her PhD, conducting research on tumor epigenetics in breast cancer at the lab of Professor Saraswati Sukumar at the Sidney Kimmel Cancer Center, Johns Hopkins University. Dr. Suijkerbuijk is actively involved in multiple phase II and III clinical trials investigating immune checkpoint inhibitors. She has published papers in prestigious journals such as Oncogene, Annals of Oncology, and the Journal of the National Cancer Institute. Throughout her career, she has received research grants from KWF and NWO and was awarded the ASCO Merit Award. Her current research focuses on clinical immunological parameters associated with immune-related adverse events and the clinicopathological factors influencing response to checkpoint inhibitors.
Department of Psychology